Practically Speaking: Adjuvant Alectenib in ALK+ NSCLC

To be added to the distribution list, please email: DDeCastro@southlake.ca

In this episode of MedOncNow, Dr. Geoff Liu will discuss resectable ALK + NSCLC in the context of adjuvant therapy. This is timely given we now have access through a company sponsored access program for Adjuvant Alectenib. 

Key Opinion Leader: 

Geoffry Liu  MD FRCPC
M. Qasim Chair in Lung Cancer Translational Research at Princess Margaret Cancer Centre,
Professor of Medicine, Pharmacology and Toxicology, Medical Biophysics, Epidemiology, Institute of Medical Science, Dalla Lana School of Public Health and the University of Toronto

Host:
Shaqil Kassam MD. MSc. FRCPC
skassam@southlake.ca
Medical Oncologist
Stronach Regional Cancer Centre, Newmarket, Ontario 

Previous episodes: https://www.blogtalkradio.com/medoncnow

X - @medoncnow